Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 2.134
+0.334 (18.56%)
Jul 27, 2026, 3:33 PM GMT
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of 6.66 million as of July 27, 2026. Its market cap has decreased by -25.74% in one year.
Market Cap
6.66M
Enterprise Value
21.65M
Revenue
3.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.13
ChartMarket Cap Chart
Since March 1, 1999, Proteome Sciences's market cap has decreased from 11.17M to 6.66M, a decrease of -40.35%. That is a compound annual growth rate of -1.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 6.66M | -9.70% |
| Dec 31, 2025 | 7.38M | -26.47% |
| Dec 31, 2024 | 10.04M | -24.94% |
| Dec 29, 2023 | 13.37M | 29.43% |
| Dec 30, 2022 | 10.33M | -31.71% |
| Dec 31, 2021 | 15.13M | 32.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.51B |
| GSK plc | 76.44B |
| Haleon | 32.02B |
| Smith & Nephew | 9.59B |
| Verici Dx | 8.01M |
| GENinCode | 6.02M |
| Thalia Therapeutics | 5.83M |
| OptiBiotix Health | 5.78M |